查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1547125

末梢血管支架植入市場:全球產業分析，規模，佔有率，成長，趨勢，2024-2033年預測

Peripheral Stent Implants Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於全球週邊血管支架植入物市場的綜合報告。該報告全面評估了市場推動因素、趨勢、機會、推動因素和挑戰等關鍵市場動態，並提供了有關市場結構的詳細見解。

主要的洞察

  • 週邊血管支架植入市場規模（2024年）：41億美元
  • 預估市值（2033 年）：75 億美元
  • 全球市場成長率（2024 年至 2033 年複合年增長率）：6.9%

週邊血管支架植入市場 - 報告範圍：

週邊血管支架植入物是重要的醫療器械，用於打開心臟以外的周邊血管系統（例如腿部和手臂）中狹窄或閉塞的動脈。這些支架可恢復正常的血流並預防肢體缺血等嚴重併發症。週邊血管支架植入物市場的推動因素包括週邊動脈疾病（PAD）盛行率的增加、支架技術的進步以及對微創手術的需求不斷增加。本報告深入介紹了不同類型的支架，包括裸金屬支架、藥物洗脫支架和生物可吸收支架，以及它們在不同患者群體中的使用。

推動市場成長的因素：

全球週邊血管支架植入物市場受到幾個關鍵因素的推動，例如人口老化、糖尿病和生活方式相關風​​險因素導致 PAD 發病率增加。藥物洗脫支架和生物可吸收支架的開發等技術進步正在改善治療結果並推動市場成長。此外，向恢復時間更短、併發症發生率更低的微創手術的轉變正在增加支架植入的採用。旨在促進血管健康的政府措施和醫療保健政策也有助於市場擴張。

市場阻礙因素：

儘管成長前景廣闊，但周邊血管支架植入市場仍面臨與高成本和報銷問題相關的挑戰。現代支架中使用的先進技術通常會導致價格高昂，這可能成為患者和醫療保健提供者的障礙，特別是在新興國家。此外，再狹窄和支架內血栓形成等併發症帶來了臨床挑戰，並可能限制市場成長。監管障礙和需要長期臨床數據來支持新產品的批准也給市場進入者帶來了挑戰。

市場機會：

由於持續的研究和開發、人們對血管疾病的認識不斷提高以及新興市場醫療保健基礎設施的不斷擴大，外周血管支架植入市場提供了巨大的增長機會。開發具有改善的生物相容性、靈活性和藥物傳輸能力的下一代支架有可能改善治療結果。進入市場的公司可以透過投資創新、與醫療保健提供者建立策略合作夥伴關係以及專注於以患者為中心的產品開發來利用這些機會。個人化醫療的興起和先進影像技術的採用也為市場成長鋪平了道路。

  • 本報告涵蓋的主要問題
  • 推動全球週邊血管支架植入物市場成長的關鍵因素是什麼？
  • 哪些類型的支架和技術在不同患者群體中處於領先地位？
  • 技術進步如何影響週邊血管支架植入物市場的競爭格局？
  • 誰是周邊血管支架植入物市場的主要參與者？
  • 全球週邊血管支架植入市場的新趨勢與未來前景如何？

目錄

第1章 摘要整理

第2章 市場概要

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 蘊藏和除外

第3章 主要市場趨勢

  • 影響市場的主要趨勢
  • 市場創新/開發趨勢

第4章 重要成功要素

  • 各製造廠商的主要的推銷策略
  • 主要的法規
  • PESTEL分析
  • 波特分析
  • 產品銷售活動
  • 產品的採用/使用情形分析
  • 退還
  • 價值鏈分析

第5章 市場背景

  • 宏觀經濟要素
  • 預測要素- 相關性及影響
  • 市場動態

第6章 COVID-19危機分析

  • COVID-19及影響分析
  • 2024年的市場情勢

第7章 全球市場規模('000單位)分析

  • 市場規模('000單位)分析，2019～2023年
  • 市場規模('000單位)預測，2024～2033年
    • 與前一年同期比較成長趨勢分析

第8章 全球市場- 價格分析

  • 不同材料的各地區價格分析
  • 價格的明細
    • 廠商級的價格設定
    • 分銷商級的價格設定
  • 世界平均價格分析基準
  • 價格設定的前提

第9章 全球市場的需求(價值或規模，10億美元)分析

  • 市場金額(10億美元)和數量(一千台)分析，2019～2023年
  • 市場規模(10億美元)和數量(一千台)的分析與預測，市場各分類，2024～2033年
    • 與前一年同期比較成長趨勢分析
    • 絕對的商機

第10章 各產品:全球市場分析

  • 簡介/主要調查結果
  • 市場規模(10億美元)和數量(一千台)分析，2019～2023年
  • 市場規模(10億美元)和數量(一千台)的分析與預測，2024～2033年
    • 裸金屬支架 (BMS)
    • 覆膜支架
    • 藥物洗脫支架 (DES)
  • 各產品市場魅力分析

第11章 動脈:全球市場分析

  • 簡介/主要調查結果
  • 市場規模(10億美元)分析，2019～2023年
  • 市場規模(10億美元)分析與預測，2024～2033年
    • 頸動脈支架
    • 大腿膝窩動脈動脈支架
    • 髂骨動脈支架
    • 膝窩動脈下動脈支架
  • Artery的市場魅力分析

第12章 各終端用戶全球市場分析

  • 簡介/主要調查結果
  • 市場規模(10億美元)分析，2019～2023年
  • 市場規模(10億美元)分析與預測，2024～2033年
    • 醫院
    • 門診病人手術中心/門診病人
  • 各終端用戶市場魅力分析

第13章 各地區全球市場分析

  • 簡介/主要調查結果
  • 市場規模(10億美元)和數量(一千台)分析，2019～2023年
  • 市場規模(10億美元)和數量(一千台)的分析與預測，2024～2033年
    • 北美
    • 南美
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東·非洲
  • 各地區市場的魅力分析

第14章 北美市場分析

第15章 南美市場分析

第16章 歐洲市場分析

第17章 東亞市場分析

第18章 南亞市場分析

第19章 大洋洲市場

第20章 中東·非洲市場分析

第21章 市場結構分析

  • 各級企業市場分析
  • 主要企業的市場佔有率分析
  • 市場影響分析

第22章 競爭分析

  • 競爭儀表板
  • 競爭基準
  • 競爭詳細內容
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Biotronik SE &Co. KG
    • Boston Scientific Corporation
    • Cook Medical, Inc.
    • Cardinal Health, Inc.
    • iVascular SLU
    • Medtronic Plc.
    • Terumo Corporation
    • WL Gore &Associates Inc.

第23章 所使用的前提條件與縮寫

第24章 調查手法

簡介目錄
Product Code: PMRREP32225

Persistence Market Research has recently released a comprehensive report on the worldwide market for peripheral stent implants. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Peripheral Stent Implants Market Size (2024E): USD 4.1 Bn
  • Projected Market Value (2033F): USD 7.5 Bn
  • Global Market Growth Rate (CAGR 2024 to 2033): 6.9%

Peripheral Stent Implants Market - Report Scope:

Peripheral stent implants are vital medical devices used to open narrowed or blocked arteries in the peripheral vascular system, including the legs, arms, and other areas outside the heart. These stents help restore proper blood flow, preventing severe complications like limb ischemia. The market for peripheral stent implants is driven by the growing prevalence of peripheral artery disease (PAD), advancements in stent technology, and increasing demand for minimally invasive procedures. The report provides insights into various types of stents, such as bare-metal stents, drug-eluting stents, and bioresorbable stents, and their applications across different patient demographics.

Market Growth Drivers:

The global peripheral stent implants market is propelled by several key factors, including the rising incidence of PAD due to an aging population, diabetes, and lifestyle-related risk factors. Technological advancements, such as the development of drug-eluting stents and bioresorbable scaffolds, are enhancing treatment outcomes and driving market growth. Additionally, the shift towards minimally invasive procedures, which offer shorter recovery times and lower complication rates, is increasing the adoption of stent implants. Government initiatives and healthcare policies aimed at improving vascular health also contribute to market expansion.

Market Restraints:

Despite promising growth prospects, the peripheral stent implants market faces challenges related to high costs and reimbursement issues. The advanced technology used in modern stents often leads to higher prices, which can be a barrier for patients and healthcare providers, especially in emerging economies. Additionally, complications such as restenosis and stent thrombosis pose clinical challenges, potentially limiting market growth. Regulatory hurdles and the need for long-term clinical data to support new product approvals also present challenges for market players.

Market Opportunities:

The peripheral stent implants market presents significant growth opportunities driven by ongoing research and development, increasing awareness of vascular diseases, and expanding healthcare infrastructure in emerging markets. The development of next-generation stents with improved biocompatibility, flexibility, and drug-delivery capabilities offers potential for enhanced treatment outcomes. Market players can capitalize on these opportunities by investing in innovation, forming strategic partnerships with healthcare providers, and focusing on patient-centric product development. The growing trend towards personalized medicine and the adoption of advanced imaging technologies also create avenues for market growth.

  • Key Questions Answered in the Report:
  • What are the primary factors driving the growth of the peripheral stent implants market globally?
  • Which types of stents and technologies are leading adoption across different patient demographics?
  • How are technological advancements influencing the competitive landscape of the peripheral stent implants market?
  • Who are the key players contributing to the peripheral stent implants market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global peripheral stent implants market?

Competitive Intelligence and Business Strategy:

Leading players in the global peripheral stent implants market, including Boston Scientific Corporation, Abbott Laboratories, and Medtronic plc, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced stent solutions, including drug-eluting stents and bioresorbable scaffolds, catering to diverse clinical needs and regulatory standards. Collaborations with healthcare providers, research institutions, and regulatory bodies facilitate market access and promote technology adoption. Emphasis on clinical outcomes, patient safety, and cost-effectiveness drives market growth and reinforces the position of key players in the evolving vascular treatment landscape.

Key Companies Profiled:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical, Inc.
  • Cardinal Health, Inc.
  • iVascular SLU
  • Medtronic Plc.
  • Terumo Corporation
  • W. L. Gore & Associates Inc.

Key Segments Covered in Peripheral Stent Implants Industry Research

Product

  • Bare Metal Stents (BMS)
  • Covered Stents
  • Drug Eluting Stents (DES)

Artery

  • Carotid Artery Stents
  • Fem-Pop Artery Stents
  • Iliac Artery Stents
  • Infrapop Artery Stents

End User

  • Hospitals
  • Ambulatory Surgical Centers/Outpatient

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Market Innovation / Development Trends

4. Key Success Factors

  • 4.1. Key Promotional Strategies, by Manufacturers
  • 4.2. Key Regulations
  • 4.3. PESTEL Analysis
  • 4.4. Porter's Analysis
  • 4.5. Product Launch Activities
  • 4.6. Product Adoption/Usage Analysis
  • 4.7. Reimbursement
  • 4.8. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Peripheral Vascular Devices Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Top Companies Historical Growth
    • 5.2.2. New Product Launches and Approvals
    • 5.2.3. Global Peripheral Vascular Diseases
    • 5.2.4. Research and Development Expenditure by Key Players
    • 5.2.5. Historic and Current Revenue of Key Players
    • 5.2.6. Rising Consumer Awareness of the Product
    • 5.2.7. Rising Adoption of Device Technological Development
    • 5.2.8. Strategic Developments by Key Players
    • 5.2.9. Increasing Adoption of Peripheral Vascular Devices for Various Arteries
    • 5.2.10. Strategic Collaborations among Players
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Artery
    • 6.1.3. By End User
    • 6.1.4. By Country
  • 6.2. 2024 Market Scenario

7. Global Market Volume ('000 Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume ('000 Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume ('000 Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Material
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) and Volume ('000 Units) Analysis, 2019-2023
  • 9.2. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis by Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Product, 2024-2033
    • 10.3.1. Bare Metal Stents (BMS)
    • 10.3.2. Covered Stents
    • 10.3.3. Drug Eluting Stents (DES)
  • 10.4. Market Attractiveness Analysis by Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Artery

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis by Artery, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Artery, 2024-2033
    • 11.3.1. Carotid Artery Stents
    • 11.3.2. Fem-Pop Artery Stents
    • 11.3.3. Iliac Artery Stents
    • 11.3.4. Infrapop Artery Stents
  • 11.4. Market Attractiveness Analysis by Artery

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis by End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by End User, 2024-2033
    • 12.3.1. Hospitals
    • 12.3.2. Ambulatory Surgical Centers/Outpatients
  • 12.4. Market Attractiveness Analysis by End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 13.1. Introduction / Key Findings
  • 13.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis, by Region, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis Forecast by Region, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East & Africa
  • 13.4. Market Attractiveness Analysis by Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Artery
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Artery
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. U.S. Market
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Artery
        • 14.8.1.2.3. By End User
    • 14.8.2. Canada Market
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Artery
        • 14.8.2.2.3. By End User

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Mexico
      • 15.3.1.2. Brazil
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By Artery
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Artery
    • 15.4.4. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Mexico Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Artery
        • 15.8.1.2.3. By End User
    • 15.8.2. Brazil Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Artery
        • 15.8.2.2.3. By End User
    • 15.8.3. Argentina Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Artery
        • 15.8.3.2.3. By End User

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Russia
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By Artery
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Artery
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Germany Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Artery
        • 16.8.1.2.3. By End User
    • 16.8.2. Italy Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Artery
        • 16.8.2.2.3. By End User
    • 16.8.3. France Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Artery
        • 16.8.3.2.3. By End User
    • 16.8.4. U.K. Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Artery
        • 16.8.4.2.3. By End User
    • 16.8.5. Spain Market Analysis
      • 16.8.5.1. Introduction
      • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.5.2.1. By Product
        • 16.8.5.2.2. By Artery
        • 16.8.5.2.3. By End User
    • 16.8.6. BENELUX Market Analysis
      • 16.8.6.1. Introduction
      • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.6.2.1. By Product
        • 16.8.6.2.2. By Artery
        • 16.8.6.2.3. By End User
    • 16.8.7. Russia Market Analysis
      • 16.8.7.1. Introduction
      • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.7.2.1. By Product
        • 16.8.7.2.2. By Artery
        • 16.8.7.2.3. By End User

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Product
    • 17.3.3. By Artery
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Artery
    • 17.4.4. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. China Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Artery
        • 17.8.1.2.3. By End User
    • 17.8.2. Japan Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Artery
        • 17.8.2.2.3. By End User
    • 17.8.3. South Korea Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Artery
        • 17.8.3.2.3. By End User

18. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Indonesia
      • 18.3.1.3. Malaysia
      • 18.3.1.4. Thailand
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Product
    • 18.3.3. By Artery
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Artery
    • 18.4.4. By End User
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. India Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Artery
        • 18.8.1.2.3. By End User
    • 18.8.2. Indonesia Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Artery
        • 18.8.2.2.3. By End User
    • 18.8.3. Malaysia Market Analysis
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By Artery
        • 18.8.3.2.3. By End User
    • 18.8.4. Thailand Market Analysis
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.4.2.1. By Product
        • 18.8.4.2.2. By Artery
        • 18.8.4.2.3. By End User

19. Oceania Market 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By Artery
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Artery
    • 19.4.4. By End User
  • 19.5. Market Trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. Australia Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Artery
        • 19.8.1.2.3. By End User
    • 19.8.2. New Zealand Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Artery
        • 19.8.2.2.3. By End User

20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis by Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkiye
      • 20.3.1.3. North Africa
      • 20.3.1.4. South Africa
      • 20.3.1.5. Rest of Middle East and Africa
    • 20.3.2. By Product
    • 20.3.3. By Artery
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By Artery
    • 20.4.4. By End User
  • 20.5. Market Trends
  • 20.6. Key Market Participants - Intensity Mapping
  • 20.7. Drivers and Restraints - Impact Analysis
  • 20.8. Country Level Analysis & Forecast
    • 20.8.1. GCC Countries Market Analysis
      • 20.8.1.1. Introduction
      • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.1.2.1. By Product
        • 20.8.1.2.2. By Artery
        • 20.8.1.2.3. By End User
      • 20.8.1.3. Turkiye Market Analysis
      • 20.8.1.4. Introduction
      • 20.8.1.5. Market Analysis and Forecast by Market Taxonomy
        • 20.8.1.5.1. By Product
        • 20.8.1.5.2. By Artery
        • 20.8.1.5.3. By End User
    • 20.8.2. South Africa Market Analysis
      • 20.8.2.1. Introduction
      • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.2.2.1. By Product
        • 20.8.2.2.2. By Artery
        • 20.8.2.2.3. By End User
    • 20.8.3. North Africa Market Analysis
      • 20.8.3.1. Introduction
      • 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.3.2.1. By Product
        • 20.8.3.2.2. By Artery
        • 20.8.3.2.3. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. Abbott Laboratories
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Sales Footprint
      • 22.3.1.4. Key Financials
      • 22.3.1.5. SWOT Analysis
      • 22.3.1.6. Key Developments
      • 22.3.1.7. Strategy Overview
        • 22.3.1.7.1. Marketing Strategy
        • 22.3.1.7.2. Product Strategy
        • 22.3.1.7.3. Channel Strategy
    • 22.3.2. B. Braun Melsungen AG
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Sales Footprint
      • 22.3.2.4. Key Financials
      • 22.3.2.5. SWOT Analysis
      • 22.3.2.6. Key Developments
      • 22.3.2.7. Strategy Overview
        • 22.3.2.7.1. Marketing Strategy
        • 22.3.2.7.2. Product Strategy
        • 22.3.2.7.3. Channel Strategy
    • 22.3.3. Biotronik SE & Co. KG
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Sales Footprint
      • 22.3.3.4. Key Financials
      • 22.3.3.5. SWOT Analysis
      • 22.3.3.6. Key Developments
      • 22.3.3.7. Strategy Overview
        • 22.3.3.7.1. Marketing Strategy
        • 22.3.3.7.2. Product Strategy
        • 22.3.3.7.3. Channel Strategy
    • 22.3.4. Boston Scientific Corporation
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Sales Footprint
      • 22.3.4.4. Key Financials
      • 22.3.4.5. SWOT Analysis
      • 22.3.4.6. Key Developments
      • 22.3.4.7. Strategy Overview
        • 22.3.4.7.1. Marketing Strategy
        • 22.3.4.7.2. Product Strategy
        • 22.3.4.7.3. Channel Strategy
    • 22.3.5. Cook Medical, Inc.
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Sales Footprint
      • 22.3.5.4. Key Financials
      • 22.3.5.5. SWOT Analysis
      • 22.3.5.6. Key Developments
      • 22.3.5.7. Strategy Overview
        • 22.3.5.7.1. Marketing Strategy
        • 22.3.5.7.2. Product Strategy
        • 22.3.5.7.3. Channel Strategy
    • 22.3.6. Cardinal Health, Inc.
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Sales Footprint
      • 22.3.6.4. Key Financials
      • 22.3.6.5. SWOT Analysis
      • 22.3.6.6. Key Developments
      • 22.3.6.7. Strategy Overview
        • 22.3.6.7.1. Marketing Strategy
        • 22.3.6.7.2. Product Strategy
        • 22.3.6.7.3. Channel Strategy
    • 22.3.7. iVascular SLU
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Sales Footprint
      • 22.3.7.4. Key Financials
      • 22.3.7.5. SWOT Analysis
      • 22.3.7.6. Key Developments
      • 22.3.7.7. Strategy Overview
        • 22.3.7.7.1. Marketing Strategy
        • 22.3.7.7.2. Product Strategy
        • 22.3.7.7.3. Channel Strategy
    • 22.3.8. Medtronic Plc.
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Sales Footprint
      • 22.3.8.4. Key Financials
      • 22.3.8.5. SWOT Analysis
      • 22.3.8.6. Key Developments
      • 22.3.8.7. Strategy Overview
        • 22.3.8.7.1. Marketing Strategy
        • 22.3.8.7.2. Product Strategy
        • 22.3.8.7.3. Channel Strategy
    • 22.3.9. Terumo Corporation
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Sales Footprint
      • 22.3.9.4. Key Financials
      • 22.3.9.5. SWOT Analysis
      • 22.3.9.6. Key Developments
      • 22.3.9.7. Strategy Overview
        • 22.3.9.7.1. Marketing Strategy
        • 22.3.9.7.2. Product Strategy
        • 22.3.9.7.3. Channel Strategy
    • 22.3.10. W. L. Gore & Associates Inc.
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Sales Footprint
      • 22.3.10.4. Key Financials
      • 22.3.10.5. SWOT Analysis
      • 22.3.10.6. Key Developments
      • 22.3.10.7. Strategy Overview
        • 22.3.10.7.1. Marketing Strategy
        • 22.3.10.7.2. Product Strategy
        • 22.3.10.7.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology